OncoMed Pharmaceuticals: ONCOMED PHARMACEUTICALS, INC. (NASDAQ:OMED) Files An 8-K Entry into a Material Definitive Agreement

ONCOMED PHARMACEUTICALS, INC. (NASDAQ:OMED) Files An 8-K Entry into a Material Definitive Agreement Item 1.01. Entry into a Material Definitive Agreement. OncoMed Pharmaceuticals Inc Exhibit EX-10.1 2 d709280dex101.htm EX-10.1 EX-10.1 Exhibit 10.1 CONTINGENT VALUE RIGHTS AGREEMENT BETWEEN ONCOMED PHARMACEUTICALS,…